2019
DOI: 10.1053/j.ackd.2019.09.006
|View full text |Cite
|
Sign up to set email alerts
|

Bone-Vascular Axis in Chronic Kidney Disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
46
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 58 publications
(46 citation statements)
references
References 168 publications
0
46
0
Order By: Relevance
“…( 35 ) Our group and others suggested that sclerostin could be the signaling molecule in the VC‐bone axis because it is highly expressed in calcified vessels and as such could potentially be secreted into circulation. ( 24,39,48 ) Our model of CKD‐induced VC was accompanied by a large increase in plasma sclerostin, which was not reflected in the uremic rat's bone's expression of sclerostin as its mRNA levels were significantly lower to normal controls. The ex vivo cultures of aorta demonstrated a high secretion of sclerostin from the calcified aorta.…”
Section: Discussionmentioning
confidence: 89%
“…( 35 ) Our group and others suggested that sclerostin could be the signaling molecule in the VC‐bone axis because it is highly expressed in calcified vessels and as such could potentially be secreted into circulation. ( 24,39,48 ) Our model of CKD‐induced VC was accompanied by a large increase in plasma sclerostin, which was not reflected in the uremic rat's bone's expression of sclerostin as its mRNA levels were significantly lower to normal controls. The ex vivo cultures of aorta demonstrated a high secretion of sclerostin from the calcified aorta.…”
Section: Discussionmentioning
confidence: 89%
“…Previous studies have shown an association between VC and low bone mineral density (BMD) or bone mass in CKD patients [6,7,22]. Osteoporosis and VC are closely related because they share pathogenic factors, such as inflammation and vitamin D, vitamin K, and Klotho deficiencies [23]. Renal osteodystrophy, which is the bone component of CKD-MBD, affects bone quality as well as bone quantity [24].…”
Section: Discussionmentioning
confidence: 99%
“…Most patients with CKD 3 to 5 stages show an increased serum parathyroid hormone level [6]. In CKD-mineral and bone disorders, circulating factors released from vessels may affect bone metabolism, while the bone disease may increase vascular calcification, highlighting the mortality risk [6,7].…”
Section: Introductionmentioning
confidence: 99%